Skip to content

A pilot study on symptomatic treatment of uncomplicated urinary tract infections in general practice.

A pilot study on symptomatic treatment of uncomplicated urinary tract infections in general practice. - Symptomatic treatment of uncomplicated urinary tract infections.

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON34751
Enrollment
100
Registered
2010-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder infection urinary tract infection

Interventions

Women who agree to participate will be advised to drink at least 2 litres of liquids per day and will be prescribed paracetamol 500 mg 2-3 times per dag 2 tablets or ibuprofen 400 mg 3 times a day d

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Women, 18-45 years of age - Symptoms and diagnosis of UTI, according to the *NHG-standaard* (symptoms: painful or burning micturition (dysuria), frequency, urgency, hematuria, suprapubic pain). - Who have provided written informed consent to participate

Exclusion criteria

Exclusion criteria: Immunocompromised patients; pregnancy; diabetes mellitus; a known urological or nephrological disorder; fever, i.e. temperature above 38°C (axillary); pain in back and-or loin (kidney region); recurrent urinary tract infections (more than three occurrences per year during the past year or a UTI in the past three months); gynaecological complaints - such as abnormal vaginal discharge, labial irritation, intermittent vaginal bleeding; symptoms present for more than three days; taken antibiotics in the past four weeks.

Design outcomes

Primary

MeasureTime frame
The primary endpoint will be acceptability (percentage of women who agreed to participate in the study).

Secondary

MeasureTime frame
Secondary endpoints will be number of *failures* and dropouts, compliance with the treatment, duration of symptoms, recurrence rates of urinary tract symptoms, complications of UTIs (pyelonephtitis, sepsis), hospital admission, quality of life as measured using SF12 health survey and absence from work.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)